Most Read Articles
27 Nov 2017
The amino sulphonic acid taurine may safely and effectively reduce portal pressure in cirrhotic patients, a study has shown.
Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
Audrey Abella, 23 Jan 2019
A single infusion of the monoclonal antibody rituximab temporarily delays the clinical onset of rheumatoid arthritis (RA) through B-cell depletion, underpinning the preventive potential of rituximab in RA development especially in high-risk individuals, according to the PRAIRI* study.
26 Nov 2019
Podcast: Professor R. Scott Wright speaks about the potential role of inclisiran in providing durable reductions in LDL-cholesterol levels in patients with atherosclerotic cardiovascular disease.

Mini-Cog assessments feasible for pharmacy students to evaluate cognitive function in elderly patients

17 Jan 2020

Elderly patients with cognitive impairment may have trouble understanding and complying with medical instructions provided during hospitalization, suggests a study. Pharmacy students, however, can perform Mini-Cog assessments to examine cognitive function, which allow them to tailor education content and involve caregivers when needed.

To evaluate the prevalence of cognitive impairment among older patients (aged ≥65 years) within 24 hours of hospital admission, Mini-Cog assessments were carried out by advanced pharmacy practice experience (APPE) students. These students on APPE rotations were trained to perform Mini-Cog assessments during routine medication education session from February 2017 to April 2017.

The prevalence of cognitive impairment as indicated by a Mini-Cog score of ≤3 was the primary endpoint. Secondary endpoints were the average number of observed Mini-Cog practice assessments required for APPE students to meet competency requirements, caregiver identification and 30-day hospital readmissions.

Twelve APPE students completed the training programme after an average of 4.4 graded Mini-Cog assessments. A total of 1,159 admissions were screened, of which 273 were included in the analysis.

More than half of these admissions (n=149; 55 percent, 95 percent confidence interval [CI], 48–61 percent) were positive for cognitive impairment. A caregiver was identified for 113 patients (41 percent, 95 percent CI, 35–47 percent), and 79 had a caregiver present at bedside during the visit.

In addition, 41 patients (15 percent, 95 percent CI, 11–20 percent) were readmitted to the hospital within 30 days of discharge.

“Older adults with cognitive impairment may have difficulty understanding and complying with medical or medication instructions provided during hospitalization which may adversely impact patient outcomes,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
27 Nov 2017
The amino sulphonic acid taurine may safely and effectively reduce portal pressure in cirrhotic patients, a study has shown.
Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
Audrey Abella, 23 Jan 2019
A single infusion of the monoclonal antibody rituximab temporarily delays the clinical onset of rheumatoid arthritis (RA) through B-cell depletion, underpinning the preventive potential of rituximab in RA development especially in high-risk individuals, according to the PRAIRI* study.
26 Nov 2019
Podcast: Professor R. Scott Wright speaks about the potential role of inclisiran in providing durable reductions in LDL-cholesterol levels in patients with atherosclerotic cardiovascular disease.